Cel-Sci Corporation

11.19+0.6500+6.17%Vol 523.94K1Y Perf -12.66%
Sep 15th, 2021 16:00 DELAYED
BID11.15 ASK11.20
Open10.50 Previous Close10.54
Pre-Market- After-Market-
 - -%  - -
Target Price
12.00 
Analyst Rating
Strong Buy 1.00
Potential %
7.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/60/67 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/3/-7 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/51/29 
Income Ranking
 —    -
Price Range Ratio 52W %
12.15 
Earnings Rating
Strong Sell
Market Cap481.48M 
Earnings Date
17th Aug 2021
Alpha0.05 Standard Deviation0.44
Beta2.24 

Today's Price Range

10.3111.40

52W Range

7.0840.91

5 Year PE Ratio Range

-6.60-1.60

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-1.32%
1 Month
23.51%
3 Months
-47.73%
6 Months
-43.88%
1 Year
-12.66%
3 Years
211.70%
5 Years
6.57%
10 Years
-88.22%

TickerPriceChg.Chg.%
CVM11.190.65006.17
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Earnings HistoryEstimateReportedSurprise %
Q03 2021-0.13-0.25-92.31
Q02 2021-0.19-0.20-5.26
Q01 2021--0.21-
Q04 2020--0.14-
Q03 2020-0.15-0.27-80.00
Q02 2020-0.16-0.17-6.25
Q01 2020-0.15-0.16-6.67
Q04 2019-0.09-0.20-122.22
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.100.00-
9/2021 QR-0.100.00-
9/2021 FY-0.79-23.44Negative
9/2022 FY-0.23-121.91Negative
Next Report Date-
Estimated EPS Next Report-0.13
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume523.94K
Shares Outstanding43.03M
Shares Float41.37M
Trades Count5.96K
Dollar Volume22.16M
Avg. Volume1.38M
Avg. Weekly Volume619.97K
Avg. Monthly Volume794.39K
Avg. Quarterly Volume1.91M

Cel-Sci Corporation (AMEX: CVM) stock closed at 11.19 per share at the end of the most recent trading day (a 6.17% change compared to the prior day closing price) with a volume of 525.26K shares and market capitalization of 481.48M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. Cel-Sci Corporation CEO is Geert R. Kersten.

The one-year performance of Cel-Sci Corporation stock is -12.66%, while year-to-date (YTD) performance is -4.03%. CVM stock has a five-year performance of 6.57%. Its 52-week range is between 7.08 and 40.91, which gives CVM stock a 52-week price range ratio of 12.15%

Cel-Sci Corporation currently has a PE ratio of -13.20, a price-to-book (PB) ratio of 8.26, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -54.66%, a ROC of -60.52% and a ROE of -84.86%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Cel-Sci Corporation, there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.13 for the next earnings report. Cel-Sci Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cel-Sci Corporation is Strong Buy (1), with a target price of $12, which is +7.24% compared to the current price. The earnings rating for Cel-Sci Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cel-Sci Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cel-Sci Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 24.90, ATR14 : 0.88, CCI20 : 11.18, Chaikin Money Flow : -0.02, MACD : 0.38, Money Flow Index : 70.23, ROC : 3.71, RSI : 53.88, STOCH (14,3) : 42.22, STOCH RSI : 0.36, UO : 47.64, Williams %R : -57.78), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cel-Sci Corporation in the last 12-months were: Bruno Baillavoine (Buy at a value of $19 416), Geert R. Kersten (Buy at a value of $200 000), John Cipriano (Sold 20 000 shares of value $371 083 ), Peter R. Young (Buy at a value of $82 798), Robert Watson (Buy at a value of $19 416)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEO: Geert R. Kersten

Telephone: +1 703 506-9460

Address: 8229 Boone Boulevard, Vienna 22182, VA, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

53%47%

Bearish Bullish

62%38%

News

Stocktwits